Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy

被引：0
|
作者：
Elizabeth Hovey
Paul de Souza
Gavin Marx
Phillip Parente
Tal Rapke
Andrew Hill
Antonino Bonaventura
Antony Michele
Paul Craft
Ehtesham Abdi
Andrew Lloyd
机构：
[1] Prince of Wales Hospital,Department of Medical Oncology
[2] University of New South Wales,undefined
[3] University of Western Sydney,undefined
[4] Sydney Haematology Oncology Clinics,undefined
[5] Box Hill Hospital,undefined
[6] Sanofi Australia Pty Ltd,undefined
[7] Gold Coast Hospital,undefined
[8] ANZGOG,undefined
[9] Calvary Hospital,undefined
[10] The Canberra Hospital,undefined
[11] The Tweed Hospital,undefined
[12] Griffith University,undefined
来源：
Supportive Care in Cancer | 2014年 / 22卷
关键词：
Breast cancer; Docetaxel; Fatigue; Prostate cancer; Modafinil; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1233 / 1242
页数：9
相关论文
共 50 条
  • [41] Donepezil for cancer fatigue: A double-blind, randomized, placebo-controlled trial
    Bruera, Eduardo
    El Osta, Badi
    Valero, Vicente
    Driver, Larry C.
    Pei, Be-Lian
    Shen, Loren
    Poulter, Valerie A.
    Palmer, J. Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (23) : 3475 - 3481
  • [42] Moral decision making under modafinil: a randomized placebo-controlled double-blind crossover fMRI study
    Thao Ngo
    Marta Ghio
    Lars Kuchinke
    Patrik Roser
    Christian Bellebaum
    Psychopharmacology, 2019, 236 : 2747 - 2759
  • [43] A randomized, double-blind, placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome
    Hickie, IB
    Wilson, AJ
    Wright, JM
    Bennett, BK
    Wakefield, D
    Lloyd, AR
    JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (09) : 643 - 648
  • [44] Efficacy and safety of oxycodone DETERx: results of a randomized, double-blind, placebo-controlled phase III study
    Kopecky, E.
    O'Connor, M.
    Varanasi, R.
    Saim, S.
    Fleming, A.
    JOURNAL OF PAIN, 2015, 16 (04): : S87 - S87
  • [45] A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients
    Doering, Gerd
    Meisner, Christoph
    Stern, Martin
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (26) : 11020 - 11025
  • [46] A Phase III, randomized, multicenter, double-blind, placebo-controlled study of ISA247 in plaque psoriasis patients
    Papp, K
    Langley, R
    Bissonnette, R
    Rosoph, L
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB9 - AB9
  • [47] Moral decision making under modafinil: a randomized placebo-controlled double-blind crossover fMRI study
    Ngo, Thao
    Ghio, Marta
    Kuchinke, Lars
    Roser, Patrik
    Bellebaum, Christian
    PSYCHOPHARMACOLOGY, 2019, 236 (09) : 2747 - 2759
  • [48] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    NEUROLOGY, 2009, 72 (09) : 806 - 812
  • [49] Phase III clinical study of maxacalcitol ointment in patients with palmoplantar pustulosis: A randomized, double-blind, placebo-controlled trial
    Umezawa, Yoshinori
    Nakagawa, Hidemi
    Tamaki, Kunihiko
    JOURNAL OF DERMATOLOGY, 2016, 43 (03): : 288 - 293
  • [50] Melatonin in Patients with Cancer Receiving Chemotherapy: A Randomized, Double-blind, Placebo-controlled Trial
    Sookprasert, Aumkhae
    Johns, Nutjaree Pratheepawanit
    Phunmanee, Anakapong
    Pongthai, Parichart
    Cheawchanwattana, Areewan
    Johns, Jeff
    Konsil, Julraht
    Plaimee, Preeyaporn
    Porasuphatana, Supatra
    Jitpimolmard, Suthiphan
    ANTICANCER RESEARCH, 2014, 34 (12) : 7327 - 7337
12345